Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06671535

Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis

Led by Saint Petersburg State University, Russia · Updated on 2025-03-04

62

Participants Needed

1

Research Sites

35 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized controlled trial aims to evaluate the effect of polymethylmethacrylate dialysis membranes use on the intensity of pruritus in patients with CKD stage 5D receiving maintenance hemodialysis. The main question it aims to answer is: Does the use of polymethylmethacrylate (PMMA) membranes reduce the intensity of pruritus in dialysis patients? Researchers will compare PMMA membranes to standard polysulfone-based membranes to see if PMMA works to reduce moderate-to-severe pruritis and pruritis-related quality of life. Participants will: * receive maintenance hemodialysis with PMMA or polysulfone membranes for 2 months; * fill in questionnaires about intensity of pruritis and its impact on daily life.

CONDITIONS

Official Title

Effect of Kidney Replacement Therapy with Polymethylmethacrylate Membranes on Pruritus-related Quality of Life in Patients Receiving Maintenance Haemodialysis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of CKD stage 5D, with maintenance hemodialysis for at least 3 months before screening
  • Moderate-to-severe pruritus with a WI-NRS score of 4 or higher
  • Adequate dialysis dose (spKt/V 21 1.4 and/or eKt/V 21 1.2)
  • Dialysis regimen of three sessions per week, each lasting at least 4 hours
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Active skin disease, cholestasis, severe secondary hyperparathyroidism, or other conditions causing pruritus as judged by the investigator
  • Patient noncompliance with the study protocol as judged by the investigator
  • Current use of haemodiafiltration

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Saint Petersburg State University Hospital

Saint Petersburg, Russia, 198103

Actively Recruiting

Loading map...

Research Team

E

Ekaterina Parshina, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here